Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week
Data to be presented from Phase II study of two patients with short bowel syndrome in an ongoing study of apraglutide BASEL, Switzerland, May 17, 2019 /PRNewswire/ — Therachon AG (“Therachon”), a clinical-stage biopharmaceutical…